Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 8/20 | 0.62 |
| ▸ | CNR2 | P34972 | 14/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27780548 | 0.95 | CNR1 (0.70) | CNR1CNR2TSHRALDH1A1TP53 | |
| SCHEMBL11164159 | 0.86 | CNR2 (0.69) | CNR1CNR2TSHRALDH1A1TP53 | |
| SCHEMBL11163820 | 0.86 | CNR2 (0.69) | CNR1CNR2TSHRALDH1A1TP53 | |
| SCHEMBL11163816 | 0.86 | CNR2 (0.69) | CNR1CNR2TSHRALDH1A1TP53 | |
| SCHEMBL16404769 | 0.86 | CNR2 (0.54) | CNR1CNR2TSHRALDH1A1TP53 | |
| SCHEMBL11164163 | 0.86 | CNR2 (0.69) | CNR1CNR2TSHRALDH1A1TP53 | |
| SCHEMBL11163812 | 0.86 | CNR2 (0.69) | CNR1CNR2TSHRALDH1A1TP53 | |
| SCHEMBL11165960 | 0.86 | CNR2 (0.70) | CNR1CNR2TSHRALDH1A1TP53 | |
| SCHEMBL11165957 | 0.86 | CNR2 (0.70) | CNR1CNR2TSHRALDH1A1TP53 | |
| SCHEMBL11165961 | 0.86 | CNR2 (0.70) | CNR1CNR2TSHRALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2698383-B1 | Detection of synthetic Cannabinoids | RANDOX LABORATORIES LTD (GB) | 2020-11-25 | — | — | EP | disclosed |
| US-9435817-B2 | Detection of synthetic cannabinoids | RANDOX LABORATORIES LIMITED (GB) | 2016-09-06 | — | — | US | disclosed |
| US-20130065323-A1 | Detection of Synthetic Cannabinoids | RANDOX LABORATORIES LIMITED (GB) | 2013-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130065323-A1 | Detection of Synthetic Cannabinoids | CNR2, CNR1, MAG | CNR1 2/4885CNR2 1/4885TSHR 1787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.